Cite
HARVARD Citation
Ginzler, E. et al. (2022). Phase III/IV, Randomized, Fifty‐Two–Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus. Arthritis & rheumatology. 74 (1), pp. 112-123. [Online].